Create an alert
to follow the executive moves at Leap Therapeutics.

Latest M&A news in Biotechnology.

Astellas Pharma has announced the acquisition of Audentes Therapeutics (posted on Dec 5, 2019).
Mesa Laboratories has announced the acquisition of Gyros (posted on Nov 1, 2019).
WebMD Health has announced the acquisition of Aptus Health (posted on Sep 30, 2019).

Most searched biographies at Leap Therapeutics

• Chris Mirabelli, Chief Executive Officer and Chairman of the Board
• William Li, Director
• Nissim Mashiach, Director

Click on an executive to view his biography >

Other contacts in the Biotechnology industry

• Fred Cohen - Director at UroGen
• Fareed Khan - Chief Financial Officer at Parallel
• Sylke Hassel - Senior Vice President and Global Head of Mammalian Busines at Lonza

Learn more about the Biotechnology industry >

Latest news about Leap Therapeutics

Leap Therapeutics on Wikipedia, Google News & Yahoo Finance

Leap Therapeutics on LinkedIn, Twitter & YouTube

Leap Therapeutics has 1,320 competitors including Alltech (United States (USA)), Aldeyra Therapeutics (United States (USA)) and Charles River Laboratories International (United States (USA)).

Contact by email its executives including Doug Onsi

Call Leap Therapeutics at +1 617....

View the org chart

Register to receive your alert

Report an error